CDH8 and cervical cancer: TCGA data for the cervical cancer cohort (N = 231) revealed distinct hypermethylation patterns among ADCY8, ZNF582, and CDH8 (Fig. 4a) for reported and non-reported clinical stages (median β value range, 0.427–0.632).